Trial Profile
Efficacy and Safety of Chidamide in CBF Leukemia
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 21 Sep 2023
Price :
$35
*
At a glance
- Drugs Cytarabine (Primary) ; Tucidinostat (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 01 Feb 2017 New trial record